| Course | DNP 647 Management of Complex and Chronic Health Problems in Pediatric Primary Care |
|---|---|
| Module | Module 4 |
| Paper type | Hosted case study thread (host case, differential table and management plan) |
| Length | About 465 words |
| Format | Discussion post with APA 7 citations |
| School | Arizona State University |
| Program | Doctor of Nursing Practice |
| Updated | October 2026 |
Free sample paper for DNP 647 Module 4
Case Study 4: Breast Buds at Six and a Half
Breast Buds at Six and a Half: A Hosted Case Study on Evaluating Early Puberty in a Girl With a Growth Spurt
Host Post: The Case
L., a girl aged 6 years 6 months, has had breast development for about four months. Her height has moved from the 50th to the 85th percentile in the past year. On examination she has Tanner stage 3 breast development and Tanner stage 2 pubic hair. Her neurological examination, including visual fields, is normal, and there are no cafe au lait spots.
Subjective Questions and Host Answers
Body odor or acne? Body odor for six months. Vaginal bleeding? None. Headaches, vision changes or vomiting? None. Exposure to estrogen creams, lavender or tea tree oils, or a parent's hormone medication? None. Prior head injury, infection or radiation? None. Family history of early puberty? Her mother had menarche at 11.
Differential Table
| Possible cause | Findings that fit | Findings that do not fit |
|---|---|---|
| Central precocious puberty | Breast and pubic hair development before 8, growth acceleration, progression over months | Laboratory confirmation pending |
| Premature thelarche | Breast development | Growth spurt, pubic hair, progression; thelarche alone is usually slow and isolated |
| Peripheral (gonadotropin-independent) puberty, such as an ovarian cyst or McCune-Albright syndrome | Breast development, rapid change | Cafe au lait spots, vaginal bleeding, abdominal findings |
| Premature adrenarche | Body odor, pubic hair | Breast development is not part of adrenarche |
| Exogenous estrogen exposure | Breast development | No identified source |
Management Plan
Most probable diagnosis: central precocious puberty.
Testing: Bone age radiograph, expected to be advanced (Kliegman et al., 2024), and early morning luteinizing hormone measured by an ultrasensitive assay with estradiol; a pubertal LH level supports central activation (Kaplowitz et al., 2016). Further stimulation testing is done by endocrinology if needed.
Referral: Refer to pediatric endocrinology promptly, since the case shows progression and growth acceleration (Kaplowitz et al., 2016).
Treatment: GnRH agonist therapy, given as an injection every one to three months or as an implant, suppresses puberty. Its main benefit is preserving adult height in girls with early-onset, progressive puberty, and psychosocial concerns are also considered (Carel et al., 2009). Brain MRI is commonly obtained in girls under 6 and in any child with neurological signs; at 6 and a half, the endocrinologist will decide based on age and findings.
Supporting article: The international consensus statement on GnRH analogs reviews the evidence for treatment benefits by age of onset and for monitoring (Carel et al., 2009).
Anticipatory guidance: Talk with L. in simple terms about body changes, reassure her that she is healthy and prepare her and her parents for questions at school. Discuss menstruation readiness in case treatment is not started.
Family websites: The Pediatric Endocrine Society patient education pages and HealthyChildren.org on puberty.
Follow-up: Monitor growth velocity and pubertal stage every three to six months with endocrinology.
References
Carel, J.-C., Eugster, E. A., Rogol, A., Ghizzoni, L., Palmert, M. R., & ESPE-LWPES GnRH Analogs Consensus Conference Group. (2009). Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics, 123(4), e752-e762. https://doi.org/10.1542/peds.2008-1783
Kaplowitz, P., Bloch, C., & Section on Endocrinology. (2016). Evaluation and referral of children with signs of early puberty. Pediatrics, 137(1), Article e20153732. https://doi.org/10.1542/peds.2015-3732
Kliegman, R. M., St. Geme, J. W., Blum, N. J., Tasker, R. C., Wilson, K. M., Schuh, A. M., & Mack, C. L. (Eds.). (2024). Nelson textbook of pediatrics (22nd ed.). Elsevier.
What the DNP 647 Module 4 instructions ask for
Week 9, after spring break and the first exam, covers endocrinology and metabolic disorders and the last hosted case of DNP 647. The pairs take the case through its familiar stages, and the discussion runs until the group settles on one diagnosis. Endocrine cases often depend on reading growth data and knowing when a finding needs a specialist, so the timing of referral is usually as important as the diagnosis itself. Pubertal staging and growth velocity are case details in their own right, so record them as precisely as the host provides them. If your role is question asker, ask about exposures and neurological symptoms early, since those answers decide whether imaging is needed. Ask early about any vaginal bleeding or rapid change in breast size, since those signs change how urgent the referral is.
How the DNP 647 Module 4 example is put together
This last hosted week begins with the host's account of the breast development, growth acceleration and Tanner staging. The subjective section asks about body odor, bleeding, neurological symptoms, estrogen exposure, prior head conditions and family history. The differential table weighs central precocious puberty against premature thelarche, peripheral puberty, adrenarche and exogenous estrogen, showing why the combined findings matter. The management plan orders a bone age and morning hormones, refers to endocrinology, explains GnRH agonist therapy and its real purpose, sets out when MRI is used, cites the AAP clinical report and an international consensus, adds guidance for talking with the child, lists websites and schedules follow-up.
Reading the DNP 647 Module 4 grading rubric
The final case study is worth 10 points, completing the 30% the series carries. In endocrine cases, credit tends to go to questions that pin down timing, progression and associated signs, a table that separates true disease from benign variants on clear grounds and a plan that starts with the right first tests, refers with appropriate urgency, explains treatment indications accurately and attends to the child's and family's feelings. Ordering broad hormone panels without a rationale, missing the meaning of growth acceleration and presenting treatment as automatic are common deductions. An attached consensus statement or trial should match the treatment decision rather than describe puberty in general terms.
DNP 647 Module 4 help: mistakes that cost marks
Read the growth chart before anything else; acceleration separates progressive puberty from isolated breast development. Start with a bone age and morning hormones and let the specialist guide further testing. Ask about estrogen-containing products in the home. Explain what treatment is for, so families understand it is not routine. Speak to the child's worries in simple language. Use the AAP clinical report as the main source. If you share the host's case and your part with the desk, it can check the order of your plan. Record both the Tanner stage and the change in height percentile, because together they make the case for referral. If the case gives a family history of early puberty, weigh it, but do not let it explain away a growth spurt in a young girl.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official Arizona State University document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.
More DNP 647 and Doctor of Nursing Practice sample papers
- DNP 647 Module 1: Case Study 1: Respiratory Disorders (Poorly Controlled Asthma)
- DNP 647 Module 2: Case Study 2: Neurological Disorders (Childhood Absence Epilepsy)
- DNP 647 Module 3: Case Study 3: Gastrointestinal Disorders (Celiac Disease)
- DNP 647 Module 5: Evidence-Based Practice Presentation: A Complex Chronic Case Off the Guideline (Pediatric Hypertension)
- DNP 713 Module 5: Culture Measurement Creative Discussion
- DNP 709 Module 3: Faces of Innovation Discussion
- DNP 645 Module 3: Case Study 3: Lower Respiratory Disorders (Pertussis in a Young Infant)
- DNP 705 Module 5: Methods Paper Part 1
DNP 647 Module 4 questions, answered
Where can I find a free DNP 647 Module 4 sample paper?
A full DNP 647 Module 4 sample is above: a hosted endocrine case study on early puberty in a girl of 6 and a half, with the differential table and a referral plan.
What is precocious puberty in girls?
Breast development or other pubertal signs before age 8 in girls; central precocious puberty results from early activation of the brain's puberty signals.
How do you tell premature thelarche from precocious puberty?
Premature thelarche is isolated, slow breast development without a growth spurt or pubic hair; precocious puberty progresses and accelerates growth.
What are the first tests for early puberty?
A bone age radiograph and early morning luteinizing hormone and estradiol, with further testing directed by pediatric endocrinology.
What does Week 9 of DNP 647 cover?
Hormones and metabolism, with the fourth and last hosted case filling the week and the eighth quiz due.